Wendy's Short Interest Climbs to 27% as Analysts Cut Targets Ahead of November Print

WEN fell 5.8% this week to $6.14, extending a month of steady selling, while short interest climbed to 27.2% of the free float and two analysts trimmed their targets in the same five-day window.

The short position has grown meaningfully since the previous note. Short interest rose 7.5% over the past week to roughly 51.7 million shares, 27.2% of the free float, up from 25.3% a week ago. That month-on-month reading, now up 7.3%, confirms bears have been adding through the decline rather than booking profits. The ORTEX short score is 77.7, the highest reading in the available history, ticking up each day this week. Availability has tightened back to 31.2%, retreating from the 40 to 41% range seen last week when borrow had briefly loosened. That is still well above the sub-20% levels of late September and early October, so squeeze pressure is limited. Cost to borrow eased 9% on the week to 2.5%, providing no particular signal either way. The FINRA fortnightly settlement figure, dated October 15, puts reported short shares at 52.3 million with days-to-cover at 9.95, corroborating the directional picture from ORTEX estimates.

Analyst conviction has deteriorated in step with the share price. Citigroup cut its target from $8.25 to $6.75 on October 23, keeping a Neutral rating. Evercore ISI lowered from $8.00 to $7.00 the same day, also unchanged at In-Line. Stephens had already trimmed from $8.00 to $7.00 on October 15. The consensus mean target is now $7.18, implying roughly 17% above the current price, but that gap reflects a string of cuts rather than new optimism. The bear case is straightforward: 4.7x net debt to EBITDA leaves little financial headroom, beef and chicken exposure pressures margins, and the quick-service market offers thin room for error in a soft consumer environment. The bull case rests on new CFO Steve Cirulis, his turnaround record at Potbelly, and the possibility that sequential comp improvement gains traction under the Project Fresh playbook. At 12.8x trailing earnings and an EV/EBITDA of 11.6x, neither multiple has compressed enough to become obviously cheap relative to the execution risk. The earnings yield factor ranks in the 92nd percentile, which is the one valuation signal pointing in a constructive direction.

The activist register adds a layer of complexity that does not appear in the price. Nelson Peltz filed a Schedule 13D/A on October 28, the most recent filing in the dataset, with a stake of 16.23% of the class, essentially unchanged from 16.24% in the prior filing. Trian Fund Management holds a further 7.8% as last reported. That combined Peltz-aligned block is above 24%, which constrains both the strategic options and the float available to other investors. Vanguard, by contrast, disclosed a drop to zero from 9.75% in a March filing, a substantial exit that is now reflected in the reduced float. BlackRock added 4.6 million shares and now holds 13.8% as of September 30, the largest recent institutional move in either direction. As always with 13D/G disclosures, these stakes are as last filed and positions below 5% may exit without a further notification.

Closest peers had a similarly bruising week. JACK fell 6.7%, LOCO dropped 6.9%, and FWRG lost 7.4%, suggesting sector-wide pressure rather than a WEN-specific event. TXRH held up better, off just 1.5%, which is consistent with its higher-quality positioning in casual dining rather than quick-service. The Q3 earnings print is scheduled for November 5. That is eight days away, and the short interest trend, the direction of analyst targets, and the level of the ORTEX short score heading into that date are the specific data points worth tracking between now and then.